Citadel Advisors’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,000
Closed -$55K 15572
2025
Q1
$55K Buy
4,000
+3,600
+900% +$52.5K ﹤0.01% 12212
2024
Q4
$6.83K Hold
400
﹤0.01% 13775
2024
Q3
$7.35K Buy
+400
New +$7.07K ﹤0.01% 13367

Other funds holding ARDT

Citadel Advisors's ARDT Position: Q2 2026 in Review

Citadel Advisors reduced its Ardent Health (ARDT) stake by 33% in Q2 2026, selling an estimated $526K and leaving 113,495 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7938.

Citadel Advisors first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $18.5M in Q3 2024. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Citadel Advisors held 113,495 shares of Ardent Health worth $1.12M as of Q2 2026.
  • Citadel Advisors sold 55,426 Ardent Health shares in Q2 2026, an estimated $526K.
  • Ardent Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7938 holding.
  • Citadel Advisors first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • Citadel Advisors's Ardent Health position peaked at $18.5M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.